Page 203 - Quantitative Imaging of Small Tumours with Positron Emission Tomography
P. 203

                                Chapter 10 References 1. van Kalmthout LWM, van Melick HHE, Lavalaye J, et al. Prospective Validation of Gallium-68 PSMA- PET/CT in Primary Staging of Prostate Cancer Patients. J Urol. 2019:101097JU0000000000000531. 2. Kaittanis C, Andreou C, Hieronymus H, et al. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J Exp Med. 2018;215:159-175. 3. Cysouw MCF, Jansen BHE, Oprea-Lager DE, et al. Machine Learning-based Analysis of [18F]PSMA PET Radiomics for Risk Stratification in Primary Prostate Cancer. Submitted. 4. Zamboglou C, Carles M, Fechter T, et al. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference. Theranostics. 2019;9:2595-2605. 5. Ferraro DA, Muehlematter UJ, Garcia Schuler HI, et al. (68)Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2019. 202 


































































































   201   202   203   204   205